Intelligence Platform
Patents
Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6200597
Formulation and use of carotenoids in treatment of cancer
expired patentUS 6197754
Suppression of tumor growth by a mini-E1A gene
expired patentUS 6194481
Mechanically strong and transparent or translucent composites made using zirconium oxide n
expired patentUS 6194176
Recombinant expression of proteins from secretory cell lines
expired patentUS 6184254
Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors
expired patentUS 6184224
Antitumor dibenzofluorene derivatives
expired patentUS 6172212
Pea3 is a tumor suppressor
expired patentUS 6171856
Methods and compositions relating to no-mediated cytotoxicity
expired patentUS 6166193
Polynucleotides encoding MY1 receptor
expired patentUS 6166079
DFMO for the treatment or prevention of cervical intraepithelial neoplasia
expired patentUS 6165990
Antisense polynucleotide
expired patentUS 6165745
Recombinant production of immunoglobulin-like domains in prokaryotic cells
expired patentUS 6165484
EDTA and other chelators with or without antifungal antimicrobial agents for the preventio
expired patentUS 6165461
Tao protein kinases and methods of use therefor
expired patentUS 6165440
Radiation and nanoparticles for enhancement of drug delivery in solid tumors
expired patentUS 6156321
Tissue factor methods and compositions for coagulation and tumor treatment
expired patentUS 6143290
Tumor regression by adenovirus expression of wild-type p53
expired patentUS 6140364
Arachidonic acid metabolite, 16-HETE
expired patentUS 6133320
Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or
expired patentUS 6132730
Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor
expired patentUS 6132729
Combined tissue factor and chemotherapeutic methods and compositions for coagulation and t
expired patentUS 6110744
Diminishing viral gene expression by promoter replacement
expired patentUS 6110889
Peptide tumor cell growth inhibitors
expired patentUS 6107457
Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated c
expired